Innoviva (INVA) EBIT Margin: 2009-2025
Historic EBIT Margin for Innoviva (INVA) over the last 17 years, with Sep 2025 value amounting to 32.08%.
- Innoviva's EBIT Margin fell 1623.00% to 32.08% in Q3 2025 from the same period last year, while for Sep 2025 it was 30.79%, marking a year-over-year decrease of 1148.00%. This contributed to the annual value of 2.19% for FY2024, which is 1094.00% down from last year.
- According to the latest figures from Q3 2025, Innoviva's EBIT Margin is 32.08%, which was down 34.02% from 48.61% recorded in Q2 2025.
- Innoviva's EBIT Margin's 5-year high stood at 8,265.41% during Q2 2021, with a 5-year trough of -1,668.23% in Q1 2025.
- Over the past 3 years, Innoviva's median EBIT Margin value was -430.50% (recorded in 2023), while the average stood at -556.58%.
- Per our database at Business Quant, Innoviva's EBIT Margin spiked by 816,941bps in 2021 and then plummeted by 875,506bps in 2022.
- Quarterly analysis of 5 years shows Innoviva's EBIT Margin stood at -611.53% in 2021, then slumped by 37,116bps to -982.68% in 2022, then surged by 55,219bps to -430.50% in 2023, then tumbled by 42,286bps to -853.36% in 2024, then tumbled by 1,623bps to 32.08% in 2025.
- Its EBIT Margin was 32.08% in Q3 2025, compared to 48.61% in Q2 2025 and -1,668.23% in Q1 2025.